MEDS
NASD DataMeds AI, Inc.$3.05 ↓ -0.02 (-0.65%) Trading Down from the previous close of $3.07
- YTD change
- -14.80%
- vs 20-day SMA
- -15.40%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
-0.51 (-14.25%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 95.8% away from all-time highs of $73.00
- MEDS is down 15% since the beginning of the year
- MEDS is down 15% over the past 12 months
- MEDS is up 252% over the past 1 month
- 13% of all MEDS investors are betting against MEDS
MEDS reads poor: the 12-month move is -14.2%.
- Previous minute
- -$0.08
- Last hour
- N/A
- Last 5 days
- -8.96%
- vs 8-day SMA
- -7.82%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
DataMeds AI, Inc. operates as a holding company centered around pharmaceuticals and healthcare services. Its business portfolio consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. The company was founded by Ajjarapu Surendra on September 6, 2022 and is headquartered in Tampa, FL.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.